FGen is an emerging Swiss biotech company active as a contract research organization in strain development and optimization. Key technologies are methods for biological engineering, such as Synthetic Biology or non-GMO methods, and a proprietary screening platform for high throughput screening. In 2022 was acquired by Ginkgo Bioworks.
FGen AG
Verified listing
-
Founded2011
-
Employees in Switzerland10-19
- Website
- Get directions
- Bookmark
- Share
- Report
- prev
- next